146 related articles for article (PubMed ID: 26848363)
21. In Reply.
Feldman SR; Anderson K
JAMA Dermatol; 2015 Oct; 151(10):1145. PubMed ID: 26465768
[No Abstract] [Full Text] [Related]
22. Primary Nonadherence in Acne Treatment: The Importance of Cost Consciousness.
Rubin CB; Lipoff JB
JAMA Dermatol; 2015 Oct; 151(10):1144-5. PubMed ID: 26465766
[No Abstract] [Full Text] [Related]
23. Pharmionics in dermatology: a review of topical medication adherence.
Lee IA; Maibach HI
Am J Clin Dermatol; 2006; 7(4):231-6. PubMed ID: 16901183
[TBL] [Abstract][Full Text] [Related]
24. [Tavegil in the dermatological practice].
Gehrels PE
Med Klin; 1968 Jun; 63(26):1043-5. PubMed ID: 4387352
[No Abstract] [Full Text] [Related]
25. Patient concerns about topical corticosteroids and impact on adherence.
Saavedra C; Cheng H
Australas J Dermatol; 2021 Aug; 62(3):419-421. PubMed ID: 34115370
[No Abstract] [Full Text] [Related]
26. Adherence to topical dermatological therapy: lessons from oral drug treatment.
Gupta G; Mallefet P; Kress DW; Sergeant A
Br J Dermatol; 2009 Aug; 161(2):221-7. PubMed ID: 19548959
[TBL] [Abstract][Full Text] [Related]
27. [Non adherent patients in dermatology].
Halioua B
Ann Dermatol Venereol; 2012 Jan; 139 Suppl 1():S22-7. PubMed ID: 22305283
[TBL] [Abstract][Full Text] [Related]
28. Patient-provider race and sex concordance and the risk for medication primary nonadherence.
Adamson AS; Glass DA; Suarez EA
J Am Acad Dermatol; 2017 Jun; 76(6):1193-1195. PubMed ID: 28522045
[No Abstract] [Full Text] [Related]
29. [Experiences with Ehrtolan in general practice].
Dietz O
Z Allgemeinmed; 1970 Oct; 46(30):1511-5. PubMed ID: 4394481
[No Abstract] [Full Text] [Related]
30. [The treatment of chronic dermatoses with glucocorticoids from the Belupo firm].
Tarasenko GN; Patronov IV; Tarasenko IuG
Voen Med Zh; 2000 Jan; 321(1):60-1. PubMed ID: 10701355
[No Abstract] [Full Text] [Related]
31. Effectiveness of topical maxacalcitol for acquired perforating disorder.
Yoshiya H; Okuyama R; Uhara H
J Am Acad Dermatol; 2013 Jun; 68(6):e181-2. PubMed ID: 23680211
[No Abstract] [Full Text] [Related]
32. [Medication adherence among elderly patients with coronary artery disease: our experience in Morocco].
Nouamou I; Mourid ME; Ragbaoui Y; Habbal R
Pan Afr Med J; 2019; 32():8. PubMed ID: 31069001
[TBL] [Abstract][Full Text] [Related]
33. Improvement of health-related quality of life and adherence to treatment with calcipotriol-betamethasone dipropionate gel in patients with psoriasis vulgaris.
Kontochristopoulos G; Kouris A; Chantzaras A; Petridis A; Yfantopoulos J
An Bras Dermatol; 2016 Apr; 91(2):160-6. PubMed ID: 27192514
[TBL] [Abstract][Full Text] [Related]
34. Adherence to over-the-counter benzoyl peroxide in patients with acne.
Huyler AH; Zaenglein AL
J Am Acad Dermatol; 2017 Oct; 77(4):763-764. PubMed ID: 28917458
[No Abstract] [Full Text] [Related]
35. Erythematous Papular Lesions on the Neck: A Quiz.
Mouchard A; Tallegas M; Machet MC; Machet L; Cornillier H
Acta Derm Venereol; 2018 Aug; 98(8):822-823. PubMed ID: 29774365
[No Abstract] [Full Text] [Related]
36. Association Between Method of Prescribing and Primary Nonadherence to Dermatologic Medication in an Urban Hospital Population.
Adamson AS; Suarez EA; Gorman AR
JAMA Dermatol; 2017 Jan; 153(1):49-54. PubMed ID: 27784045
[TBL] [Abstract][Full Text] [Related]
37. A randomized controlled clinical study to evaluate the effectiveness of an active moisturizing lotion with colloidal oatmeal skin protectant versus its vehicle for the relief of xerosis.
Kalaaji AN; Wallo W
J Drugs Dermatol; 2014 Oct; 13(10):1265-8. PubMed ID: 25607563
[TBL] [Abstract][Full Text] [Related]
38. [Dermatologic experience with Robusanon paste].
Ortmann KL
Landarzt; 1967 Feb; 43(6):283-5. PubMed ID: 5591255
[No Abstract] [Full Text] [Related]
39. Poor medication adherence in patients with psoriasis and a successful intervention.
Wang W; Qiu Y; Zhao F; Zhang F
J Dermatolog Treat; 2019 Sep; 30(6):525-528. PubMed ID: 29790405
[No Abstract] [Full Text] [Related]
40. Palpable migratory arciform erythema: hydroxychloroquine as a possible therapeutic option.
Tognetti L; Cinotti E; Fimiani M; Rubegni P
G Ital Dermatol Venereol; 2019 Jun; 154(3):357-360. PubMed ID: 29144102
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
